Edmund Lee

Company: Regulus Therapeutics
Job title: Executive Director, Biology
Seminars:
Inhibition of miR-17 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 9:30 am
Investigating preclinical data supporting miR-17 as therapeutic target for ADPKD Assessing translational research leading up to the development of clinically-relevant urinary biomarker for ADPKD Exploring clinical data demonstrating target engagement and proof of mechanism in ADPKD patientsRead more
day: Day Two